A significant shift in Canadian drug policy has taken place, as the regulators announce the legalization of psilocybin mushrooms for therapeutic treatment. Until now, these substances were strictly restricted, but a increasing body of studies suggests they potentially offer relief for emotional conditions like depression. The new policy represents